|
Dr Martens PLC on Wednesday said it is ‘on track’ with its strategic objectives as it left full-year guidance unchanged. In a brief trading update ahead of its annual general meeting in London on Wednesday, the Northamptonshire, England-based boot maker said trading since the start of the financial year has been in line with expectations with the outlook and guidance for financial 2027 unchanged. Dr Martens said its largest market, the US, continues to grow, with wholesale business particularly encouraging. Its largest Asian markets, Japan and South Korea, are both performing well, while European markets are performing as expected, against a challenging consumer backdrop, the company said. ‘We are focused on our ambition to become the world’s most-desired premium footwear brand and are on track with our strategic objectives for FY27.’ In May, Dr Martens outlined its aims for the current financial year, including driving full price revenue mix in the UK, and the DACH region incorporating Germany, Austria and Switzerland. In addition, it aims to introduce an ‘innovative’ new sandals range, launch new ‘retail concepts’ in ‘key’ cities globally and ‘unlock’ operating model and technology benefits. Shares in Dr Martens rose 2.2% to 74.30 pence each in London on Wednesday. Copyright 2026 Alliance News Ltd. All Rights Reserved.
|
